RadNet, Inc. (NASDAQ:RDNT) Holdings Trimmed by Global Alpha Capital Management Ltd.

Global Alpha Capital Management Ltd. decreased its holdings in RadNet, Inc. (NASDAQ:RDNT) by 3.4% during the third quarter, HoldingsChannel.com reports. The firm owned 960,034 shares of the medical research company’s stock after selling 34,100 shares during the quarter. RadNet makes up about 4.3% of Global Alpha Capital Management Ltd.’s holdings, making the stock its 3rd biggest holding. Global Alpha Capital Management Ltd.’s holdings in RadNet were worth $66,617,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of RDNT. Covestor Ltd grew its position in shares of RadNet by 10,875.0% during the 3rd quarter. Covestor Ltd now owns 439 shares of the medical research company’s stock worth $30,000 after buying an additional 435 shares in the last quarter. Nisa Investment Advisors LLC grew its position in shares of RadNet by 774.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 848 shares of the medical research company’s stock worth $50,000 after buying an additional 751 shares in the last quarter. GAMMA Investing LLC grew its position in shares of RadNet by 74.7% during the 2nd quarter. GAMMA Investing LLC now owns 865 shares of the medical research company’s stock worth $51,000 after buying an additional 370 shares in the last quarter. Highline Wealth Partners LLC bought a new stake in RadNet during the third quarter valued at about $68,000. Finally, Peterson Financial Group Inc. purchased a new position in RadNet in the third quarter valued at about $90,000. Hedge funds and other institutional investors own 77.90% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the company. Barclays upgraded RadNet from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $57.00 to $79.00 in a research note on Friday, September 6th. Sidoti upgraded RadNet to a “strong-buy” rating in a research note on Friday, October 4th. Truist Financial lifted their target price on RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, September 23rd. Finally, Jefferies Financial Group lifted their target price on RadNet from $75.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, September 19th. One analyst has rated the stock with a sell rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $74.75.

RadNet Price Performance

Shares of RDNT stock opened at $79.85 on Wednesday. RadNet, Inc. has a fifty-two week low of $31.55 and a fifty-two week high of $93.65. The firm has a market capitalization of $5.91 billion, a price-to-earnings ratio of -1,140.55 and a beta of 1.75. The company has a debt-to-equity ratio of 0.89, a quick ratio of 2.16 and a current ratio of 2.16. The stock’s 50-day simple moving average is $69.65 and its 200-day simple moving average is $63.37.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.